Jamie Dimon warns of hidden credit risks as stress builds in regional banks and private equity. Analysts turn to long-duration Treasuries and small-cap hedges as potential portfolio protection.
Friday’s session (Oct 17) delivered a mixed, slightly negative breadth day, but the 1-week picture remains constructive thanks to earlier gains. Participation above the 20-day remains soft, new highs dwindled, and monthly breadth is still net-negative—suggesting a market pausing rather than breaking.
The two sides are negotiating a $350 billion investment fund aimed at capping U.S. tariffs on Korean goods at 15%, with final details still under discussion.
President Donald Trump warned that the U.S. economy would face significant challenges if the Supreme Court rules against the majority of the tariffs imposed this year.
The biotechnology sector is currently experiencing a significant surge in investor attention, characterized by a blend of cautious optimism and strategic focus. As of October 2025, this heightened interest is not merely an isolated phenomenon but rather a potent indicator of broader market movements, significantly impacting stock futures and the
After two constructive sessions, breadth rolled over hard on Thursday, with decliners re-taking a clear majority and short-term momentum slipping back below key thresholds. Intermediate-term gauges remain intact, but they’re deteriorating.
Approval ratings for President Donald Trump are near record lows in his second presidential term. The government shutdown could be weighing on the results.
